⌘K

Login Start Free

Home/Filings/4/0001209191-23-041338

4//SEC Filing

Longpre Lara 4

Accession 0001209191-23-041338

CIK 0001759425other

View on SEC.gov Company Profile

Filed

Jul 4, 8:00 PM ET

Accepted

Jul 5, 7:37 PM ET

Size

4.8 KB

Accession

0001209191-23-041338

Insider Transaction Report

Form 4

Period: 2023-07-03

Mirum Pharmaceuticals, Inc.MIRM

Chief Development Officer

Transactions

Sale
Common Stock
2023-07-03$25.65/sh−1,004$25,749→ 105,839 total

Footnotes (1)

[F1]Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Mirum Pharmaceuticals, Inc.

CIK 0001759425

Entity typeother

Related Parties

1

filerCIK 0001780347

Filing Metadata

Form type: 4
Filed: Jul 4, 8:00 PM ET
Accepted: Jul 5, 7:37 PM ET
Size: 4.8 KB

View on SEC.gov